Previous Article | Next Article 
Journal of Clinical Microbiology, April 2001, p. 1402-1406, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1402-1406.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Are Two Cryptococcus neoformans Strains
Epidemiologically Linked?
Dea
Garcia-Hermoso,1
Françoise
Dromer,1
Simone
Mathoulin-Pelissier,2 and
Guilhem
Janbon1,*
Unité de Mycologie, Institut Pasteur,
Paris,1 and Institut Bergonié,
Bordeaux,2 France
Received 27 November 2000/Returned for modification 11 January
2001/Accepted 5 February 2001
 |
ABSTRACT |
The aim of this study was to standardize a method to determine
whether two strains of Cryptococcus neoformans could be
considered epidemiologically linked. We hypothesized that strains
isolated from the same patient were epidemiologically linked and that
those isolated from different patients were unrelated. We used 17 environmental isolates and 97 clinical isolates from 31 patients
diagnosed with cryptococcosis (1 to 14 isolates per patient). Using the
plasmid pCnTel-1-labeled probe CENTEL, we were able to differentiate
some unrelated strains that yielded the same hybridization profile with
the C. neoformans middle-repetitive-element CNRE-1 probe. The genetic distances separating the strains isolated from the same
patient and those separating the strains isolated from different patients were estimated, and the results obtained with the two probes
were compared. Analysis of the results enabled the calculation of two
Dice coefficient limits defining the zones containing the pairs of
linked strains and the pairs of unrelated strains, as well as an
intermediate uncertainty zone for which it was not possible to
establish whether the pairs of strains were linked.
 |
INTRODUCTION |
Cryptococcus neoformans
is an encapsulated yeast that can cause life-threatening meningitis in
immunocompromised patients (16). This encapsulated
basidiomycete exists in three varieties: C. neoformans var.
grubii (serotype A) (7) and C. neoformans var. neoformans (serotype D), both with
worldwide distributions, and C. neoformans var.
gattii (serotypes B and C), which is limited to tropical and
subtropical regions (14). After the classical biotyping
methods, this serotype classification was the first tool developed to
study the epidemiology of cryptococcosis. The recent availability of
DNA fingerprinting techniques (see reference 3 for a review) has
greatly extended our knowledge of C. neoformans epidemiology
over the last few years. Indeed, randomly amplified polymorphic DNA,
restriction fragment length polymorphism (RFLP), karyotyping, and
multilocus enzyme electrophoresis have helped answer several important
questions. For example, it has been shown that patients are usually
infected by a single strain, and that strain is responsible for the
recurrent episodes of the infection (2, 20). Using
independent molecular tools, we were recently also able to demonstrate
the existence of a dormant form of crytococcosis (9).
However, it was still impossible to determine with certainty whether
two strains were epidemiologically linked. In our previous study, the
CNRE-1 probe, which had the highest discriminatory power to date, was
occasionally unable to differentiate between two strains that were
obviously unrelated since they had been isolated in two different
countries (9). On the other hand, using the same probe, we
found that two strains isolated from the same patient sometimes
generated slightly different hybridization patterns, probably due to
the microevolution of strains during the infection. Thus, in some
instances, two unrelated strains seemed to be genetically closer than
two linked strains. This paradox was due to the poor characterization
of the performances of the methods. Indeed, a common problem
encountered with typing techniques used for epidemiological studies of
mycoses is difficulty in distinguishing the microevolution of a strain
from differences between two unrelated strains (18). We
compared the abilities of CNRE-1 (19) and a new probe
named CENTEL to establish whether two C. neoformans strains
are linked. To assess the performances of the probes, we calculated the
sensitivity and specificity for different Dice coefficient cutoff
values and used a statistical method usually applied to the evaluation
of diagnostic tools (receiver operating characteristic [ROC]
analysis) (12). Finally, well-characterized clinical and
environmental isolates were used to estimate the smallest genotypic
differences separating two unrelated strains and the largest genotypic
differences separating two linked strains.
 |
MATERIALS AND METHODS |
Patients and strains.
The 17 environmental isolates from
different countries and the 97 clinical isolates of C. neoformans var. grubii recovered from 31 patients used
in this study were described previously (9). All strains
were stored frozen in 40% glycerol at
80°C and grown in YPD medium
(10 g of yeast extract, 20 g of Bacto Peptone, and 20 g of
glucose per liter) at 30°C.
RFLP analysis.
Genomic DNA was prepared as described
elsewhere (23). The UT-4p probe has previously been shown
to be a valuable molecular tool to study the epidemiology of C. neoformans (4, 10, 22). It was obtained by labeling a
linear telomeric plasmid directly isolated from C. neoformans cells. In 1992, Edman described an Escherichia
coli/C. neoformans shuttle plasmid containing the same telomeric
repeat sequence and the same URA5 gene (5). This plasmid, named pCnTel-1 (generously provided by B. Wickes [San
Antonio, Texa]), can be easily purified from E. coli
transformant colonies by using a Qiagen (Hilden, Germany) plasmid kit,
and we used it to label a probe that we named CENTEL. DNA from the CNRE-1 phage, a generous gift from E. Spitzer and S. Spitzer (Stony Brook, N.Y.) (19), was purified by using a Qiagen lambda
kit. All isolates were typed by Southern blot analysis after labeling of the probes with digoxigenin -11-dUTP by using a DIG-High Prime kit
(Boehringer Mannheim, Mannheim, Germany). Genomic DNA was digested with
AccI for hybridization with CENTEL or SstI for
hybridization with CNRE-1. The resulting fragments were then
electrophoretically separated through a 0.8% agarose gel and
transferred onto positively charged nylon membranes (Boehringer
Mannheim). After overnight hybridization at 65°C (CENTEL) or 68°C
(CNRE-1) and washes, bands were visualized according to the
manufacturer's instructions.
Statistical analysis.
DNA fingerprint patterns were
analyzed, as previously described (9), using Taxotron
software (11), which compares two profiles by calculating
the Dice coefficient complement (number of different bands/total number
of fragments in the two profiles). As had many authors in the past
(e.g., et al. [20] and Sullivan et al.
[21]), we considered two strains isolated from the same patient to be genetically linked derivaties of a unique infectious strain and two strains isolated from two different patients to be
unrelated. The strains recovered from different patients were isolated
from unrelated individuals living in different towns in France and are
unlikely to be the same, whereas reinfection by a new strain is clearly
the exception (21).
To assess the capacities of the probes to determine linkages, we
calculated the sensitivity and specificity for various cutoff values of
the genetic distances measured by the
Dice coefficient. For the sensitivity and specificity calculations, a
true positive or true negative was considered to be a pair of unrelated
or linked strains, respectively, within a given range of Dice
coefficients. The following formulas were used: sensitivity = true
positives/(true positives + false negatives), and specificity = true negatives/(true negatives + false positives). The ROC
curves were then established by plotting, for various cuttoff-value
ranges of Dice coefficients, the sensitivity against the value of
1
specificity. We calculated the areas under the curves
(X) to estimate the global performance of the method
(12). The Dice coefficient cutoff values (Y and Z, delineating an uncertainty zone) giving X
0.99 were defined. Finally, the discriminatory power of each probe
was calculated using Hunter's formula (13).
 |
RESULTS |
Study of environmental isolates.
Using CENTEL to type 17 C. neoformans var. grubii strains isolated from
the environment, 17 different profiles were obtained, whereas CNRE-1
generated only 15 different profiles (9). As shown in Fig.
1, strain Af2 (Togo) and strain Af1
(Morocco) had the same hybridization pattern when CNRE-1 was employed,
whereas their profiles differed when CENTEL was used.

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 1.
Southern blot hybridization patterns of five
environmental C. neoformans isolates generated with CNRE-1
(A) or CENTEL (B). A 1-kb ladder (GibcoBRL) was used as a molecular
size marker; positions of its components are indicated to the left (A)
or to the right (B) of the gels.
|
|
Study of clinical isolates.
Ninety-seven clinical strains
isolated from 31 different patients used in our previous study
(9) were then tested with both probes; profiles specific
to each patient were obtained. Sometimes hybridization patterns
obtained with serial isolates from a particular patient showed some
heterogeneity (Table 1). For example, all
nine isolates collected from patient P6 yielded the same hybridization
profile when CNRE-1 was used, but as many as seven different patterns
could be distinguished with CENTEL (Fig.
2). No clear-cut relationship between the
organ from which the strain had been recovered and the corresponding
profiles could be established.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Numbers of profiles obtained using the CENTEL and CNRE-1
probes with isolates from 31 patients with cryptococcosis
|
|

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 2.
Southern blot hybridization patterns of nine serial
clinical C. neoformans strains isolated from patient 6, generated with CNRE-1 (A) and CENTEL (B). A 1-kb ladder (GibcoBRL) was
used as a molecular size marker (M); positions of its components are
indicated to the left of the gels (in kilobases).
|
|
Stability and reproducibility of the hybridization profiles.
It has been previously shown that, after subcloning of
isolates, CNRE-1 was able to generate reproducible and stable
hybridization patterns (19, 20). We tested the
reproducibility of CENTEL profiles. Although the hybridization patterns
were highly reproducible from one DNA preparation to another (data not
shown), when 20 subcloned colonies from the same plate were tested
simultaneously, one exhibited microevolution of the CENTEL pattern
(data not shown).
Genetic distances between pairs of linked or unrelated
strains.
For example, the first strain isolated, from patient P1
was compared with every other strain isolated from the same patient, yielding seven pairs of related strains. The same strain was
compared with the 89 strains isolated from the other patients,
generating 89 pairs of unrelated strains. Thus, for CNRE-1 and
CENTEL, 363 and 365 pairs of unrelated strains and 234 and 231 pairs of
linked strains could be established, respectively. The small difference in strain pair numbers between the two methods was due to the exclusion
from the final analysis of a few profiles because of poor-quality
hybridizations. Then, using the Dice coefficient complement, we
calculated the genetic distances separating the two members of every
pair of epidemiologically linked strains and every pair of
epidemiologically unrelated strains. The results obtained with CNRE-1
and CENTEL were compared (Fig. 3), and
the discriminatory power of each probe was calculated (D = 1 and D = 0.9, respectively). Using the mean Dice
coefficients to evaluate the performances of CNRE-1 and CENTEL,
respectively, we found genetic distances of 0.06 and 0.11 between the
linked strains and 0.46 and 0.62 for the unrelated strains. Considering
the two probes, the lowest Dice coefficients separating two unrelated strains (0.349 with CENTEL and 0.049 with CNRE-1) were lower than the
highest Dice coefficients separating two epidemiologically linked
strains (0.449 with CENTEL and 0.149 with CNRE-1). We determined two
Dice coefficient cutoff values (Y and Z)
delineating the zones containing the pairs of strains that had at least
a 99% chance of being genetically linked (0 to Y) or
unrelated (Z to 1), as well as an intermediate uncertainty
zone (Y to Z). Using CENTEL, a pair of strains
with a Dice coefficient below 0.250 or above 0.449 had a 99.4%
(X
0.994) chance of being genetically linked or
unrelated, respectively. For CNRE-1, a pair of strains with a Dice
coefficient below 0.049 or above 0.149 had a 99.9% chance (X
0.999) of being epidemiologically linked or
unrelated, respectively. The uncertainty zone was wider for CENTEL
(0.250 to 0.449) than for CNRE-1 (0.050 to 0.149).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Schematic representation of the genetic distances
between pairs of strains recovered from the same patient (linked)
(black bars), or from different patients (unrelated) (gray bars)
determined with CNRE-1 or CENTEL. Three zones were established: 0 to
Y, in which a pair of strains could be considered
epidemiologically linked; Z to 1, in which two strains could
be considered epidemiologically unrelated; and a zone of uncertainty
(Y to Z). The number of pairs of strains for each
of the Dice coefficient values is indicated above the corresponding
column.
|
|
 |
DISCUSSION |
UT-4p is one of the previously described tools for C. neoformans epidemiological studies (4, 10, 22). With
this probe, the differences seen between hybridization profiles of
strains are probably due to telomeric- or subtelomeric-region length
heterogeneity (15). We developed a similar tool using the
telomere-containing sequence plasmid pCnTel-1 (5) as a
substrate to label a probe we named CENTEL.
We showed that CENTEL profiles were reproducible (for 39 isolates typed
at least twice independently) when the DNA was extracted from cultures
inoculated with cell en masse, but not with a single colony, since
subcloning led in some cases to microevolution of the hybridization
profiles. Therefore, every strain had to be stored in 40% glycerol at
80°C and regrown without subcloning. This method of culture
conservation had been already applied to Candida albicans
and C. neoformans because of their natural phenotypic and
genotypic variabilities (6, 17).
Our main objective was to estimate the shortest genetic distance
separating two epidemiologically unrelated strains. This information
had rarely been sought, since in most cases the authors tended to
arbitrarily decide the minimal numbers of different bands separating
two unrelated strains. Two strains yielding very similar patterns with
one typing method are commonly considered to be epidemiologically
linked, but the degree of similarity that should be observed between
two linked strains has never been assessed or standardized.
Our working hypothesis defined two strains isolated from the same
patient as being epidemiologically linked (2, 20). Two
strains isolated from two different patients were considered to be
epidemiologically unrelated, since transmission of cryptococcal strains
between patients has never been suggested in the literature and the
infectious strain seems to be acquired very early in life (1,
9).
Based on the numbers of patterns obtained with the environmental
isolates using CENTEL (17 for 17 specimens) and CNRE-1 (15 for 17 specimens) and employing Hunter's formula (15), CENTEL could be classified as having the higher discriminatory power. However,
when looking at the results obtained with clinical isolates, one could
still wonder which tool was indeed the best since visual differences
between profiles from serial (linked) isolates were sometimes larger
than those between profiles obtained from isolates recovered from
different patients (unrelated). Thus, to calculates the genetic
distances between strains, the Dice coefficients for CNRE-1 and CENTEL
were determined for each pair of clinical strains (363 and 365 pairs of
unrelated and 231 and 234 pairs of linked strains, respectively). We
first noticed that with both probes, the mean distance between two
strains was shorter for linked than for unrelated pairs of strains,
thus indicating a patient-by-patient clustering of isolates. We
delineated two zones of certainty, 0 to Y and Z
to 1, that differed first by cutoff values and width, depending on the
true linkage or true lack of linkage, and second by the probe used
(CENTEL shifted to the right). Similarly, the uncertainty zone
(Y to Z) was wider for CENTEL than for CNRE-1.
Based on these findings, it could have been concluded that CENTEL
would be inappropriate for the epidemiological study of cryptococcosis, but based on the calculation of the classical discriminatory power (i.e., the ability to discriminate unrelated isolates), CENTEL was more powerful than CNRE-1. This discrepancy clearly shows that one typing method alone cannot unequivocally answer
all questions. In fact, none of the unrelated strains shared the same
profile using CENTEL, whereas this was not true for CNRE-1, as shown
with the African environmental isolates, thereby limiting the
usefulness of the latter probe for the demonstration of linkage between
two strains. Profile differences between linked isolates were rarely
seen with CNRE-1, making it a good tool to affirm that two strains were
unrelated when the profiles differed (with a Dice coefficient of >0.15
in our hands). In contrast, profile differences between linked strains
were better seen with CENTEL, thereby making it a more appropriate tool
for the study of what has been considered to date as microevolution
during infection (8, 21).
In conclusion, every time the epidemiology of a microorganism is
addressed, the epidemiological tool has to be evaluated using an
adapted population of isolates for which maximum information is
available. Thus, we think that the 97 clinical isolates used in the
previous and present studies represent a suitable population for the
assessment of a molecular typing method to study cryptococcosis epidemiology.
 |
ACKNOWLEDGMENTS |
We thank A. Casadevall (Albert Einstein College of Medicine,
Bronx, N.Y.), J. M. Clauson (Western Kentucky University, Bowling Green), S. Kohno (Nagasaki University School of Medicine, Nagasaki, Japan), and D. Swinne (Institute of Tropical Medicine, Antwerp Belgium)
for supplying the environmental isolates used in this study. We are
grateful to E. Spitzer and S. Spitzer (State University of New York at
Stony Brook) for the generous gift of the CNRE-1 probe and B. Wickes
(University of Texas Health Science Center at San Antonio for providing
the plasmid pCnTel-1. We also thank Olivier Ronin for serotyping the
cryptococcal isolates and J. Jacobson for editorial assistance. We are
grateful for the collaboration of the French Cryptococcosis Study
Group, which includes clinicians and microbiologists from various
hospitals in France. Those who participated in collecting strains used
in this specific study are listed here (in alphabetical order by city):
M. E. Bougnoux, S. Morelon, and E. Rouveix (Boulogne-Billancourt); C. Passa Gaudouen, B. Michel, G. Otterbein, and J. Roucoules
(Bry-sur-Marne); J. M. Korach (Châlon-en-Champagne); B. Salles
and C. Sire (Chalon/Saône); M. Gauthier and O. Salmon (Evry); F. Botterel and J. F. Delfraissy (Le Kremlin-Bicêtre); M. A.
Desailly and H. Maisonneuve (La Roche/Yon); D. Bouhour, E. Dannaoui, D. Peyramond, and M. A. Piens (Lyon); O. Morin and P. Poirier (Nantes);
M. Gari Toussaint and P. Dellamonica (Nice); B. Hery and J. Y. Leberre
(St. Nazaire); M. F. Biava and C. Rabaud (Vandoeuvre-les-Nancy); and
C. Fontier and E. Mazards (Valenciennes); and, in Paris, C. Chochillon,
X. Duval, and J. L. Vildé (Hôpital Bichat); M. Kazatchkine, V. Lavarde, and C. Piketty (Hôpital Broussais); B. Dupont (Institut Pasteur); L. Baril, F. Bricaire, J. Carrière, A. Datry, S. Herson, and C. Trivalle (Hôpital
Pitié-Salpêtrière); G. Delzant and G. Kac (Hôpital Tenon); J. Gilquin (Hôpital St.-Joseph); and D. Toubas (Reims).
Financial support for this work was provided by SIDACTION and the
Pasteur Institute (Contrat de Recherche Clinique).
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Unité de Mycologie, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: (33) 1 45688356. Fax: (33) 1 45688420. E-mail: janbon{at}pasteur.fr.
 |
REFERENCES |
| 1.
|
Abadi, J., and L. Pirofski.
1999.
Antibodies reactive with the cryptococcal polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.
J. Infect. Dis.
180:915-919[CrossRef][Medline].
|
| 2.
|
Brandt, M. E.,
L. C. Hutwagner,
L. A. Klug,
W. S. Baughman,
D. Rimland,
E. A. Graviss,
R. J. Hamill,
C. Thomas,
P. G. Pappas,
A. L. Reingold,
R. W. Pinner, and the Cryptococcal Disease Active Surveillance Group.
1996.
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States.
J. Clin. Microbiol.
34:912-917[Abstract].
|
| 3.
|
Casadevall, A., and J. R. Perfect.
1998.
Cryptococcus neoformans.
ASM Press, Washington, D.C.
|
| 4.
|
Dromer, F.,
A. Varma,
O. Ronin,
S. Mathoulin, and B. Dupont.
1994.
Molecular typing of Cryptococcus neoformans serotype D clinical isolates.
J. Clin. Microbiol.
32:2364-2371[Abstract/Free Full Text].
|
| 5.
|
Edman, J. C.
1992.
Isolation of telomerelike sequences from Cryptococcus neoformans and their use in high-efficiency transformation.
Mol. Cell. Biol.
12:2777-2783[Abstract/Free Full Text].
|
| 6.
|
Franzot, S. P.,
J. Mukherjee,
R. Cherniak,
L.-C. Chen,
J. S. Hamdan, and A. Casadevall.
1998.
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
Infect. Immun.
66:89-97[Abstract/Free Full Text].
|
| 7.
|
Franzot, S. P.,
I. F. Salkin, and A. Casadevall.
1999.
Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.
J. Clin. Microbiol.
37:838-840[Abstract/Free Full Text].
|
| 8.
|
Fries, B., and A. Casadevall.
1998.
Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice.
J. Infect. Dis.
178:1761-1766[CrossRef][Medline].
|
| 9.
|
Garcia-Hermoso, D.,
G. Janbon, and F. Dromer.
1999.
Epidemiological evidence for dormant Cryptococcus neoformans infection.
J. Clin. Microbiol.
37:3204-3209[Abstract/Free Full Text].
|
| 10.
|
Garcia-Hermoso, D.,
S. Mathoulin-Pélissier,
B. Couprie,
O. Ronin,
B. Dupont, and F. Dromer.
1997.
DNA typing suggests pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype D.
J. Clin. Microbiol.
35:2683-2685[Abstract].
|
| 11.
|
Grimont, P. A. D.
1998.
Taxotron's user's manual.
Institut Pasteur, Paris, France.
|
| 12.
|
Hanley, J. A., and B. J. McNeil.
1982.
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Radiology
143:29-36[Abstract/Free Full Text].
|
| 13.
|
Hunter, P. R.
1990.
Reproducibility and indices of discriminatory power of microbial typing methods.
J. Clin. Microbiol.
28:1903-1905[Abstract/Free Full Text].
|
| 14.
|
Kwon-Chung, K. J., and J. E. Bennett.
1984.
Epidemiologic differences between the two varieties of Cryptococcus neoformans.
Am. J. Epidemiol.
120:123-130[Abstract/Free Full Text].
|
| 15.
|
Louis, E. J.
1995.
The chromosome ends of Saccharomyces cerevisiae.
Yeast
11:1553-1573[CrossRef][Medline].
|
| 16.
|
Mitchell, T. G., and J. R. Perfect.
1995.
Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans.
Clin. Microbiol. Rev.
8:515-548[Abstract].
|
| 17.
|
Rustchenko-Bulgac, E. P.
1991.
Variations of Candida albicans electrophoretic karyotypes.
J. Bacteriol.
173:6586-6596[Abstract/Free Full Text].
|
| 18.
|
Soll, D. R.
2000.
The ins and outs of DNA fingerprinting the infectious fungi.
Clin. Microbiol. Rev.
13:332-370[Abstract/Free Full Text].
|
| 19.
|
Spitzer, E. D., and S. G. Spitzer.
1992.
Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans.
J. Clin. Microbiol.
30:1094-1097[Abstract/Free Full Text].
|
| 20.
|
Spitzer, E. D.,
S. G. Spitzer,
L. F. Freundlich, and A. Casadevall.
1993.
Persistance of initial infection in recurrent Cryptococcus neoformans meningitis.
Lancet
341:595-596[CrossRef][Medline].
|
| 21.
|
Sullivan, D.,
K. Haynes,
G. Moran,
D. Shanley, and D. Coleman.
1996.
Persistance, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients.
J. Clin. Microbiol.
34:1739-1744[Abstract].
|
| 22.
|
Varma, A., and K. J. Kwon-Chung.
1992.
DNA probe for strain typing of Cryptococcus neoformans.
J. Clin. Microbiol.
30:2960-2967[Abstract/Free Full Text].
|
| 23.
|
Varma, A., and K. J. Kwon-Chung.
1991.
Rapid method to extract DNA from Cryptococcus neoformans.
J. Clin. Microbiol.
29:810-812[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, April 2001, p. 1402-1406, Vol. 39, No. 4
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.4.1402-1406.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Del Poeta, M.
(2004). Role of Phagocytosis in the Virulence of Cryptococcus neoformans. Eukaryot Cell
3: 1067-1075
[Full Text]
-
Garcia-Hermoso, D., Dromer, F., Janbon, G.
(2004). Cryptococcus neoformans Capsule Structure Evolution In Vitro and during Murine Infection. Infect. Immun.
72: 3359-3365
[Abstract]
[Full Text]